Resmed Inc. buy UBS Group AG
Start price
24.04.25
/
50%
€207.50
Target price
24.04.26
€251.00
Performance (%)
-10.14%
End price
25.04.26
€186.45
Summary
This prediction ended on 25.04.26 with a price of €186.45. The price of Resmed Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.14%. UBS_Group_AG has a follow-up prediction for Resmed Inc. where he still thinks Resmed Inc. is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | 5.421% | 5.421% | -23.214% |
| iShares Core DAX® | 3,26 % | 2,07 % | 10,10 % |
| iShares Nasdaq 100 | 5,70 % | -0,60 % | 28,97 % |
| iShares Nikkei 225® | 7,77 % | -4,75 % | 52,09 % |
| iShares S&P 500 | 2,80 % | 2,25 % | 23,75 % |
Comments by UBS_Group_AG for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target lowered by analysts at UBS Group AG from $290.00 to $285.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten